A client taking ivabradine develops an irregular rhythm at 118/min after diltiazem was added. Which action should the nurse take?
1Administer both medications as scheduled because a ventricular rate above 100/min rules out excessive rate-slowing or interaction effects.
2Hold the medication, obtain a rhythm strip, and notify the prescriber about suspected atrial fibrillation and interaction.✓ Correct answer
3Give an additional dose to slow the irregular rate, then assess the rhythm after the next scheduled administration.
4Document the rhythm as a visual-effect equivalent and continue both agents unless the client reports syncope.
Explanation
Ivabradine increases atrial-fibrillation risk, and diltiazem can increase ivabradine exposure while also lowering heart rate. New irregular tachycardia requires rhythm assessment, medication hold according to protocol, and prescriber notification.
Quick answer Treat new irregular rhythm during ivabradine as atrial fibrillation until evaluated.
Why this is correct Ivabradine is discontinued if atrial fibrillation develops. Diltiazem and verapamil should be avoided because pharmacokinetic and negative-chronotropic effects increase risk.
Easy analogy or mental picture Build a medication safety chain: identify the cue cluster, connect it to the drug mechanism, stop preventable exposure, stabilize the client, and verify the response with measurable findings.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving treatment for the underlying condition.
Why the other choices are wrong Options that rely on one reassuring value, continue a suspect exposure, bypass monitoring, or delay escalation leave the medication hazard active.
References
1DailyMed: CORLANOR (ivabradine) prescribing informationBradycardia, atrial fibrillation, rhythm monitoring, and avoidance of verapamil or diltiazem
Medication-safety reviewVerify the indication, current assessment, laboratory trend, timing, route, interactions, authorized action, and measurable follow-up.